CELG-RI
Bristol-Myers Squibb Company Ce NYSE$0.08
Mkt Cap $157.6M
52w Low $0.08
5.1% of range
52w High $0.08
50d MA $0.11
200d MA $0.07
P/E (TTM)
0.0x
EV/EBITDA
2.0x
P/B
0.0x
Debt/Equity
2.6x
ROE
—
P/FCF
0.0x
RSI (14)
—
ATR (14)
—
Beta
-0.48
50d MA
$0.11
200d MA
$0.07
Avg Volume
34.7K
About
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 1.42 | 1.58 | +11.3% | 0.08 | +16.3% | +9.1% | — | — | — | — | — | — |
| Feb 5, 2026 | AMC | 1.23 | 1.26 | +2.4% | 0.09 | -1.7% | -1.9% | -1.9% | -12.6% | +9.2% | +7.8% | +14.6% | — |
| Oct 30, 2025 | AMC | 1.52 | 1.08 | -28.9% | 0.03 | -14.5% | +0.0% | -14.5% | +8.2% | +12.2% | -7.7% | -22.7% | — |
| Apr 24, 2025 | AMC | 1.49 | 1.21 | -18.8% | 0.03 | -0.7% | -1.7% | -1.7% | -1.7% | -1.7% | +35.6% | +5.4% | — |
Recent Filings
· Source: massive.com